BackORIC Pharmaceuticals Overview
ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals Target Price

Where could ORIC trade next? Consensus target price: $15.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.47

Average Target Price

$15.0011.4% upside

1 analysts in the last 4 months

High: $15 | Low: $15

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-15Goldman Sachs$1511.4% upsideOpen
2026-02-24H.C. WainwrightRobert Burns$2585.6% upsideOpen
2026-02-24OppenheimerMatthew Biegler$1511.4% upsideOpen
2026-01-07Piper SandlerKelsey Goodwin$2263.3% upsideOpen
2025-12-08Wells Fargo$2585.6% upsideOpen
2025-11-14H.C. Wainwright$2370.7% upsideOpen
2025-09-04GuggenheimBrad Canino$1833.6% upsideOpen
2025-05-06OppenheimerMatthew Biegler$1210.9% downsideOpen
2024-09-05Stifel NicolausBradley Canino$2048.5% upsideOpen
2024-03-21H.C. WainwrightRobert Burns$2155.9% upsideOpen
2024-03-12WedbushDavid Nierengarten$2048.5% upsideOpen
2024-03-12OppenheimerMatthew Biegler$1726.2% upsideOpen
2022-04-05CitigroupYigel Nochomovitz$748% downsideOpen

ORIC Pharmaceuticals (ORIC) FAQ

ORIC Pharmaceuticals (ORIC) currently reports a target price of $15. Use the charts on this page to explore ORIC Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for ORIC Pharmaceuticals is $15, about 11.4% upside from the current share price of $13.47. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $15, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ORIC Pharmaceuticals, and consider following ORIC for alerts when major investors trade the stock.

ORIC Pharmaceuticals is classified in the Healthcare sector. On target price, it currently shows $15. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORIC with unrelated industries.